Strides Ventures raises 85 crore from SIDBI
Stride Ventures, a venture debt fund firm, has raised up to 85 crore from Small Industries Development Bank of India (SIDBI). The funds received from12-11-2020
12-11-2020
Strides Pharma Science Ltd - 532531 - Corporate Action-Updates on Amalgamation/ Merger / Demerger
Order of the National Company Law Tribunal, Mumbai Bench sanctioning merger of wholly owned subsidiaries12-11-2020
Strides accelerates R&D; spend to beef up its drug portfolio
Plans to launch 10 new products by the end of this fiscal11-11-2020
Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India10-11-2020
Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 10, 2020 for Vimal Kumar S, Vimal Kumar S - HUF & Ambemata Securities10-11-2020
Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Karuna Business Solutions LLP09-11-2020
Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pronomz Ventures LLP09-11-2020
Strides Pharma Science Ltd - 532531 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding request received for issue of duplicate share certificate under Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 Rama Vijayashree06-11-2020
Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 04, 2020 for Pronomz Ventures LLP , Chayadeep Properties Pvt Ltd & Agnus Holdings Pvt Ltd04-11-2020
China Slams The Brakes On Ant Group's $37 Billion Listing
The Shanghai stock exchange said it had suspended the company's initial public offering on its tech-focused STAR Market, prompting Ant to also freeze the Hong Kong leg of its dual listing...04-11-2020